Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bracco boosts nuclear medicine line with purchase:

This article was originally published in Clinica

Executive Summary

Italian company Bracco is to strengthen its nuclear medicine business through the acquisition of the products and intellectual property from Resolution Pharmaceutical. Resolution, a private Canadian company, specialises in diagnosis, staging and treatment of neoplasias. "Not only does this acquisition broaden our pipeline of new potential products for diagnosis and therapy of tumours, but it also significantly strengthens our patent portfolio," said Michael Tweedle, president of Bracco Research USA.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT069473

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel